Search - tctmd.com

Displaying 441 - 460 of 463

Sort: Relevancy | Date

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Daily News

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

September 19, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

News Daily News

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

L.A. McKeown

May 03, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Steady Decline Seen in PCI Use Over Last Few Years

L.A. McKeown

February 21, 2011

News Daily News

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

February 13, 2011

News Daily News

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Jason Kahn

January 23, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

Advertisement

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

New-Generation DES Reduce Restenosis, Stent Thrombosis

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Women Have Less Neointimal Hyperplasia Than Men With ZES

Paclitaxel Balloon Maintains Advantage at 5 Years

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Steady Decline Seen in PCI Use Over Last Few Years

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content